All Stories

  1. Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study
  2. Indacaterol/glycopyrronium reduces the risk of clinically important deterioration after direct switch from baseline therapies in patients with moderate COPD: a post hoc analysis of the CRYSTAL study
  3. “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD
  4. A year in the life of German patients with COPD: the DACCORD observational study